LDLR and neoplasm: The results were corroborated by the tumor weights at the endpoint: OxPt/SN38 treatment with concurrent IgG injection showed a TGI of 92% while OxPt/SN38 treatment with concurrent LDLR blockade showed a TGI of 57% (Figure S30b, c, Supporting Information).